Visteon Q3 Sales USD 970 Million Vs. IBES Estimate USD 937.9 Million

By Reuters News

Oct 22 (Reuters) - Visteon Q3 net income USD 5 million.

  • outlook FY adjusted EBITDA USD 370-410 million vs. IBES estimate USD 471.5 million
  • outlook FY sales USD 3,800-3,850 million vs. IBES estimate USD 3,799 million

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk